PHARMACEUTICALS Merck & Co. sells consumer products unit to Bayer

被引：0

作者：

Jarvis, Lisa

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2014年 / 92卷 / 19期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：7 / 7

页数：1

相关论文

共 50 条

[31] Merck & Co. joins race for COVID-19 vaccines and therapies
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2020, 98 (23) : 12 - 12
[32] Pharmaceuticals - Teva makes an offer for Bayer's French generics unit
Morrison, S
CHEMICAL WEEK, 2002, 164 (06) : 15 - 15
[33] Merck & Co. to buy Acceleron and its TGF-β ligand traps
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 806 - 806
[34] Merck & Co., Inc.: analysis of patenting 1998-2002
Norman, P
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (07) : 1037 - 1044
[35] Merck & Co. to buy Acceleron and its TGF-β ligand traps
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) : 806 - 806
[36] Kishna Kalicharran, PhD, MSc, MBA, Merck & Co., North Wales, PA
Kalicharran, Kishna
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 : 18S - 18S
[37] Merck & Co. buys TNF-superfamily-targeting antibody for $10.8 billion
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (06) : 435 - 435
[38] Merck & Co. pays US$1.35 billion for LSD1 inhibitors
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 6 - 6
[39] Merck & Co. pays US$1.35 billion for LSD1 inhibitors
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (01) : 6 - 6
[40] Merck & Co. buys TNF-superfamily-targeting antibody for $10.8 billion
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 435 - 435

← 1 2 3 4 5 →